The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBaronsmead Vt Regulatory News (BVT)

Share Price Information for Baronsmead Vt (BVT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 52.50
Bid: 51.00
Ask: 54.00
Change: 0.00 (0.00%)
Spread: 3.00 (5.882%)
Open: 52.50
High: 52.50
Low: 52.50
Prev. Close: 52.50
BVT Live PriceLast checked at -
Baronsmead Venture Trust is an Investment Trust

To achieve long-term investment returns for private investors by investing primarily in a diverse portfolio of UK growth businesses, whether unquoted or traded on AIM.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Offer for Subscription - Update

6 Nov 2017 11:15

RNS Number : 6578V
Baronsmead Venture Trust PLC
06 November 2017
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA OR ANY JURISDICTION IN WHICH THE SAME COULD BE UNLAWFUL. THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE AN OFFER OF SECURITIES FOR SALE IN ANY JURISDICTION, INCLUDING IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA.

BARONSMEAD VENTURE TRUST PLC

6 November 2017

Offer For Subscription - Update

On 4 October 2017 Baronsmead Venture Trust plc (the "Company") launched an offer for subscription to raise up to £21 million (the "Offer"). The Offer was open exclusively to satisfy subscriptions from Existing Shareholders until 16 October 2017 and was then open to all investors. The Company issued 19,228,312 New Shares at an issue price of 94.80 pence on 26 October 2017 under the Offer.

The directors of the Company have been advised that, on the basis of Subscription Forms received during the course of 3 November 2017, the Offer has become fully subscribed. In accordance with the terms of the Offer investors whose Subscription Forms are received after this time will have their Subscription automatically allocated to the Baronsmead Second Venture Trust plc offer for subscription, which remains open, unless the investor has specifically stipulated on the Subscription Form that they do not want this to happen.

A further announcement in relation to the second allotment of New Shares under the Offer will be made shortly.

Definitions

Terms defined in the Prospectus have the same meanings in this announcement unless the context requires otherwise.

Further information

For further information please contact.

Michael Probin - VCT investor relations

Livingbridge VC LLP

020 7506 5796

Notes

This announcement does not constitute or form part of any offer to issue or sell, or any solicitation of any offer to subscribe or purchase, any investment in any jurisdiction, nor shall it (or the fact of its distribution) form the basis of, or be relied on in connection with, any contract therefor.

The issue and the distribution of this announcement and the Prospectus in certain jurisdictions may be restricted by law and persons into whose possession any document or other information referred to in this announcement and the Prospectus comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
OUPEAFFKEFEXFFF
Date   Source Headline
29th Apr 20243:30 pmRNSNet Asset Value(s)
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20243:17 pmRNSTotal Voting Rights
28th Mar 202411:00 amRNSShare Allotment,Total Voting Rights,Close of Offer
19th Mar 20245:37 pmRNSClose of Offer to New Applications
18th Mar 20244:46 pmRNSDirector/PDMR Shareholding
15th Mar 20244:04 pmRNSTransaction in Own Shares
6th Mar 20243:00 pmRNSNet Asset Value(s)
6th Mar 20241:22 pmRNSResult of AGM
1st Mar 202410:20 amRNSTotal Voting Rights
15th Feb 20242:05 pmRNSDirector/PDMR Shareholding
15th Feb 20242:00 pmRNSAllotment of Shares and Total Voting Rights
7th Feb 202410:00 amRNSNet Asset Value(s)
2nd Feb 20248:00 amRNSIntention to Utilise Over-allotment Facility
1st Feb 20245:18 pmRNSTotal Voting Rights
1st Feb 20247:00 amRNSTransaction in Own Shares
30th Jan 202412:01 pmRNSDirector/PDMR Shareholding
30th Jan 202412:00 pmRNSDirector/PDMR Shareholding
26th Jan 20242:30 pmRNSAllotment of Shares and Total Voting Rights
24th Jan 20245:00 pmRNSNet Asset Value(s)
24th Jan 20244:00 pmRNSNet Asset Value(s)
22nd Jan 20243:00 pmRNSOffer Update Extension of Early Bird Discount Date
19th Jan 20242:35 pmRNSIssue of Supplementary Prospectus
5th Jan 202411:36 amRNSChange of allotment date - correction
4th Jan 20243:45 pmRNSChange of allotment date
2nd Jan 202411:00 amRNSTotal Voting Rights
22nd Dec 20237:00 amRNSAnnual Financial Report
12th Dec 20235:40 pmRNSTransaction in Own Shares
6th Dec 20231:30 pmRNSNet Asset Value(s)
24th Nov 20231:27 pmRNSPublication of a Prospectus/Offer for Subscription
22nd Nov 20237:00 amRNSCompliance with Market Abuse Regulation ("MAR")
14th Nov 202310:01 amRNSUpdate on Offer for Subscription
6th Nov 20234:01 pmRNSNet Asset Value(s)
27th Oct 20231:30 pmRNSNet Asset Value(s)
19th Oct 20234:51 pmRNSDirectorate Change
12th Oct 202311:22 amRNSAppointment of Non-Executive Director
2nd Oct 20234:00 pmRNSTotal Voting Rights
28th Sep 20235:52 pmRNSTransaction in Own Shares
12th Sep 20236:28 pmRNSTransaction in Own Shares - Replacement
12th Sep 20235:20 pmRNSTransaction in Own Shares
5th Sep 202311:00 amRNSIntention to Fundraise
4th Aug 20234:00 pmRNSNet Asset Value(s)
1st Aug 20231:52 pmRNSTotal Voting Rights
27th Jul 20234:11 pmRNSTransaction in Own Shares
24th Jul 20232:00 pmRNSNet Asset Value(s)
3rd Jul 202311:26 amRNSTotal Voting Rights
20th Jun 20233:45 pmRNSTransaction in Own Shares
13th Jun 20237:00 amRNSHalf-yearly Report
6th Jun 20235:30 pmRNSNet Asset Value(s)
12th May 20237:00 amRNSCompliance with the Market Abuse Regulation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.